Francis Duhay, Director at enVVeno Medical Corp (NVNO), sold 11 shares at $11.21 ($123) on 2026-09-11, disclosed to the SEC on 2026-09-14.
Scheduled sale ($123) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NVNO | SELL | 2025-12-12 | $2K | — | Filing → |
| NVNO | SELL | 2025-09-17 | $4K | — | Filing → |
| NVNO | BUY | 2025-01-03 | $500K | — | Filing → |